Skip to content
Gut Podcast cover art

All episodes

Gut Podcast, 135 episodes. Page 2 of 2.

#
Title
101

Development of an enhanced human gastrointestinal epithelial culture system

102

Helicobacter pylori targets cancer-associated apical-junctional constituents

103

Diagnosis and management of acute kidney injury in patients with cirrhosis

104

Demonstration of the usefulness of epigenetic cancer risk prediction

105

XIAP variants in male Crohn’s disease

106

Cell lineage distribution atlas reveals heterogeneous gland populations in the gastric antrum

107

Classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease

108

Update on basic and clinical aspects of eosinophilic oesophagitis

109

AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition

110

Besifovir versus entecavir in Asian patients with chronic hepatitis B

111

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea

112

Recent advances in clinical practice challenges and opportunities in the management of obesity

113

Amniotic stem cell treament for necrotic enterocolitis

114

British Society of Gastroenterology guidelines on diagnosing and managing Barrett’s oesophagus

115

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients

116

A systematic approach to therapeutic target selection in oesophago-gastric cancer

117

Gut podcast: Treatment of pancreatic fibrosis with siRNA

118

Intra-tumoural stroma as a predictor of survival in patients with gastric cancer

119

Probiotics in health and disease

120

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission

121

mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway

122

Endoscopic improvement of mucosal lesions in patients with ileocolonic Crohn’s disease

123

Bowel cancer screening in England

124

PUFAS and neoplasms

125

Cancer treatment induced gastrointestinal symptoms

126

Bifidobacterium and gastrointestinal inflammation

127

High-fat diet and gut microbiota

128

Management of Helicobacter pylori infection

129

Assessment of colorectal cancer molecular features

130

Probiotic and postbiotic activity in health and disease

131

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

132

Outcomes of the Bowel Cancer Screening Programme in England

133

Mucosal healing in inflammatory bowel disease

134

Interleukin 13 and its role in gut defence and inflammation

135

Revising the classification of acute pancreatitis